Literature DB >> 11508473

Comparison of three generic questionnaires measuring quality of life in adolescents and adults with cystic fibrosis: the 36-item short form health survey, the quality of life profile for chronic diseases, and the questions on life satisfaction.

L Goldbeck1, T G Schmitz.   

Abstract

OBJECTIVE: To compare different generic instruments in measuring quality of life and to demonstrate dimensions of quality of life (QL) in patients with cystic fibrosis (CF).
METHODS: The short-form-36 health survey (SF-36), the quality of life profile for chronic diseases (PLC), and the questions on life satisfaction (FLZ(M)) were simultaneously employed in a cross-sectional study with 70 adolescents and adults with CF. The different concepts of the measures were compared. Internal consistency (Cronbach's alpha), convergent and construct validity (correlation patterns, common factor analysis), and external validity (correlations with symptom and pulmonary function scores, with intensity of therapy; comparisons with healthy peers) of the three instruments were investigated.
RESULTS: Similar reliability, but different validity of the questionnaires are demonstrated. Seventy-three percent of the total variance across the three measures could be explained with a seven-factor-solution: (1) physical functioning (19.3% of total variance), (2) mental health (19.3%), (3) social integration (7.5%), (4) role function/pain (7.5%), (5) economic/material living conditions (7.5%), (6) partnership/family (6.7%) and (7) anxiety (5.2%). DISCUSSION: The different validity of the instruments has to be considered in chosing a questionnaire appropriate to the purpose of measuring. Shortcomings of each instrument can be overcome by multimethod designs and by developing disease-specific scales.

Entities:  

Mesh:

Year:  2001        PMID: 11508473     DOI: 10.1023/a:1016711704283

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  5 in total

1.  Gene therapy for cystic fibrosis: a psychosocial study of trial participants.

Authors:  C Blair; E Kacser; D Porteous
Journal:  Gene Ther       Date:  1998-02       Impact factor: 5.250

2.  The quality of well-being in cystic fibrosis.

Authors:  D M Orenstein; P A Nixon; E A Ross; R M Kaplan
Journal:  Chest       Date:  1989-02       Impact factor: 9.410

3.  Quality of life in patients with cystic fibrosis.

Authors:  W de Jong; A A Kaptein; C P van der Schans; G P Mannes; W M van Aalderen; R G Grevink; G H Koëter
Journal:  Pediatr Pulmonol       Date:  1997-02

4.  Quality of life in adults with cystic fibrosis.

Authors:  J Congleton; M E Hodson; F Duncan-Skingle
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

5.  Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity?

Authors:  D Staab; K Wenninger; N Gebert; K Rupprath; S Bisson; M Trettin; K D Paul; K M Keller; U Wahn
Journal:  Thorax       Date:  1998-09       Impact factor: 9.139

  5 in total
  11 in total

1.  Development of life satisfaction in young physicians: results of the prospective SwissMedCareer Study.

Authors:  Richard Klaghofer; Martina Stamm; Claus Buddeberg; Georg Bauer; Oliver Hämmig; Michaela Knecht; Barbara Buddeberg-Fischer
Journal:  Int Arch Occup Environ Health       Date:  2010-06-12       Impact factor: 3.015

Review 2.  Are factor analytical techniques used appropriately in the validation of health status questionnaires? A systematic review on the quality of factor analysis of the SF-36.

Authors:  Henrica C W de Vet; Herman J Adèr; Caroline B Terwee; François Pouwer
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

3.  Validating a self-report measure of global subjective well-being to predict adverse clinical outcomes.

Authors:  L Douglas Ried; Michael J Tueth; Eileen Handberg; Harry Nyanteh
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

4.  The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial.

Authors:  Jenny Sadler Gallagher; Henry A Feldman; Natalie A Stokes; Marc R Laufer; Mark D Hornstein; Catherine M Gordon; Amy D DiVasta
Journal:  J Pediatr Adolesc Gynecol       Date:  2016-02-27       Impact factor: 1.814

5.  Growing up with cystic fibrosis: achievement, life satisfaction, and mental health.

Authors:  Tanja Besier; Lutz Goldbeck
Journal:  Qual Life Res       Date:  2012-01-04       Impact factor: 4.147

Review 6.  Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications.

Authors:  Mirella De Civita; Dean Regier; Abul H Alamgir; Aslam H Anis; Mark J Fitzgerald; Carlo A Marra
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

7.  The Caregiver Quality of Life Cystic Fibrosis (CQOLCF) scale: modification and validation of an instrument to measure quality of life in cystic fibrosis family caregivers.

Authors:  Whitney Boling; David M Macrina; John P Clancy
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

8.  Standard values and relationship-specific validity of the Bielefeld Relationship Expectations Questionnaire (BFPE).

Authors:  Katja Petrowski; Hendrik Berth; Sören Paul; Gesine Grande; Yve Stöbel-Richter; Elmar Brähler
Journal:  BMC Med Res Methodol       Date:  2010-10-13       Impact factor: 4.615

9.  Gender and age differences in domain-specific life satisfaction and the impact of depressive and anxiety symptoms: a general population survey from Germany.

Authors:  Isolde Daig; Peter Herschbach; Anja Lehmann; Nina Knoll; Oliver Decker
Journal:  Qual Life Res       Date:  2009-05-09       Impact factor: 4.147

10.  The effect of inpatient rehabilitation programmes on quality of life in patients with cystic fibrosis: a multi-center study.

Authors:  Tim G Schmitz; Lutz Goldbeck
Journal:  Health Qual Life Outcomes       Date:  2006-02-03       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.